Currently Viewing:
Newsroom
Currently Reading
Continuing Systemic Treatment in Cutaneous T-cell Lymphoma Associated With Lower Healthcare Costs
March 20, 2019 – Mary Caffrey
Adherence to COPD Treatment Lower With 3 Inhalers Compared With 2
March 20, 2019 – Jaime Rosenberg
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20, 2019 – Wallace Stephens
What We're Reading: Postpartum Depression Drug Approval; Marijuana and Psychosis; Mississippi Abortion Bill
March 20, 2019 – AJMC Staff
AHIP, Employer Groups Seek Congressional Action on Surprise Medical Bills
March 19, 2019 – Allison Inserro
The Current Landscape of CGRP Inhibitor Coverage
March 19, 2019 – Samantha DiGrande
COPD Symptoms Improved in Case Study of Endobronchial Valve Treatment
March 19, 2019 – Wallace Stephens
What We're Reading: Ohio Work Requirements; Healthcare Data Breaches; Patients Try to Lower Drug Costs
March 19, 2019 – AJMC Staff
MS May Not Flare Post Pregnancy, Study Finds
March 18, 2019 – Samantha DiGrande

Cervical Cancer Screening Rates "Unacceptably Low," Researchers Find

Jaime Rosenberg
Less than two-thirds of women aged 30 to 65 years were up to date with cervical cancer screenings in 2016. The percentage was even lower for women aged 21 to 29, with just over half up to date on screenings.
As January marks Cervical Health Awareness Month, healthcare stakeholders are emphasizing the importance of screening for the disease, which has reduced the incidence of cervical cancer death by more than 60% since its introduction in the 1950s. However, the percentage of women who get screened for cervical cancer may be far lower than national data suggest, according to Mayo Clinic researchers.

As of 2012, cancer screening guidelines recommend Papanicolaou (Pap) testing every 3 years for women aged 21 to 65 years or Pap–human papilloma virus (HPV) testing every 5 years for women aged 30 to 65 years.

Publishing their study results in Journal of Women’s Health, researchers obtained data from the Rochester Epidemiology Project for women 16 years and older living in Olmstead, Minnesota, from 2005 to 2016 and found that screening rates for all eligible women were well below the Healthy People 2020 goals. The findings contradict self-reported data from the 2015 National Health Interview Study, in which 81% of women reported compliance.

In 2016, less than two-thirds (64.6%) of the 27,4178 women aged 30 to 65 years were up to date with cervical cancer screening, most of whom (60.8%) were screened with a Pap–HPV cotest within 5 years. Among women aged 21 to 29 years, about half (53.8%) were adherent to screening, with the majority screened with Pap tests (47.3%).

“Total Pap and Pap–HPV cotest screening rates in 2016 for adolescent girls and women age 16 to less than 21 years and more than 65 years were appropriately low, 2.1% and 8.8%, respectively, and were consistent with recommendations against screening women in those age groups,” the researchers noted.

Looking across the study period, there were significant declines in Pap test rates in all age groups but significant increases in Pap–HPV cotesting. While Pap testing rates decreased from 62.8% in 2005 to 47.3% in 2016 among women aged 21 to 29 years, rates dropped from 67.5% to just 3.9% among women aged 30 to 65 years. However, during the same time period, cotesting rates varied significantly for women aged 21 to 29 years but consistently remained under 10%. Among women aged 30 to 65 years, there was a significant increase in cotesting between 2007 and 2016, jumping from 10% to 60.8%, which suggests increasing adoption of 2012 screening recommendations.

The researchers also observed troubling disparities across racial/ethnic groups. “African-American women were 50% less likely to be up-to-date on cervical cancer screening than white women in 2016,” said Kathy MacLaughlin, MD, family medicine specialist, Mayo Clinic, and the study’s lead author, in a statement. “Asian women were nearly 30% less likely than white women to be current on screening. These racial disparities are especially concerning.”

According to MacLaughlin, clinicians must start thinking outside the box on ways to best reach these women to ensure they are receiving these life-saving screening tests.

Reference

MacLaughlin K, Jacobson R, Breitkopf C, et al. Trends over time in Pap and Pap–HPV cotesting for cervical cancer screening [published online January 7, 2019]. J Womens Health. doi: 10.1089/jwh.2018.7380.

Related Articles

Four in Five Mentally Ill Women on California Medicaid Not Screened for Cervical Cancer
Cemiplimab, in GOG 3016, Looks to Break New Ground for Immunotherapy in Cervical Cancer
Pembrolizumab Indications Expand to Include Cervical Cancer
Study Suggests HPV Test More Accurate Than Pap Smear for Cervical Cancer Screening
USPSTF Updates Cervical Cancer Screening Recommendations
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!